These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 29883237)

  • 1. Stem cell transplantation in sickle cell disease: therapeutic potential and challenges faced.
    Leonard A; Tisdale JF
    Expert Rev Hematol; 2018 Jul; 11(7):547-565. PubMed ID: 29883237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic transplantation strategies including haploidentical transplantation in sickle cell disease.
    Gluckman E
    Hematology Am Soc Hematol Educ Program; 2013; 2013():370-6. PubMed ID: 24319206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic stem cell transplantation for sickle cell disease: state of the science.
    Talano JA; Cairo MS
    Eur J Haematol; 2015 May; 94(5):391-9. PubMed ID: 25200500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curative options for sickle cell disease: haploidentical stem cell transplantation or gene therapy?
    Leonard A; Tisdale J; Abraham A
    Br J Haematol; 2020 May; 189(3):408-423. PubMed ID: 32034776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes and long-term effects of hematopoietic stem cell transplant in sickle cell disease.
    Inam Z; Tisdale JF; Leonard A
    Expert Rev Hematol; 2023; 16(11):879-903. PubMed ID: 37800996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic stem cell transplantation and cellular therapy in sickle cell disease: where are we now?
    Tanhehco YC; Bhatia M
    Curr Opin Hematol; 2019 Nov; 26(6):448-452. PubMed ID: 31483336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic Transplant and Gene Therapy: Evolving Toward a Cure.
    Lawal RA; Walters MC; Fitzhugh CD
    Hematol Oncol Clin North Am; 2022 Dec; 36(6):1313-1335. PubMed ID: 36400545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative donor: αß/CD19 T-cell-depleted haploidentical hematopoietic stem cell transplantation for sickle cell disease.
    Foell J; Kleinschmidt K; Jakob M; Troeger A; Corbacioglu S
    Hematol Oncol Stem Cell Ther; 2020 Jun; 13(2):98-105. PubMed ID: 32202248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy for sickle cell disease.
    Leonard A; Tisdale JF
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):542-547. PubMed ID: 38066927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haematopoietic stem cell transplantation for sickle cell disease - current practice and new approaches.
    Arnold SD; Bhatia M; Horan J; Krishnamurti L
    Br J Haematol; 2016 Aug; 174(4):515-25. PubMed ID: 27255787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic hematopoietic stem cell transplantation from sibling and unrelated donors in pediatric patients with sickle cell disease-A single center experience.
    Kogel F; Hakimeh D; Sodani P; Lang P; Kühl JS; Hundsdoerfer P; Künkele A; Eggert A; Oevermann L; Schulte JH
    Pediatr Transplant; 2021 Mar; 25(2):e13892. PubMed ID: 33098344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogenic hematopoietic stem cell transplantation in sickle cell disease.
    Furstenau DK; Tisdale JF
    Transfus Apher Sci; 2021 Feb; 60(1):103057. PubMed ID: 33485798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Debating the Future of Sickle Cell Disease Curative Therapy: Haploidentical Hematopoietic Stem Cell Transplantation vs. Gene Therapy.
    Kassim AA; Leonard A
    J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36013014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curative therapy for hemoglobinopathies: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo stem cell gene therapy versus allogeneic hematopoietic stem cell transplantation.
    Leonard A; Bertaina A; Bonfim C; Cohen S; Prockop S; Purtill D; Russell A; Boelens JJ; Wynn R; Ruggeri A; Abraham A
    Cytotherapy; 2022 Mar; 24(3):249-261. PubMed ID: 34879990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic stem cell transplantation for sickle cell disease: The changing landscape.
    Kassim AA; Sharma D
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):259-266. PubMed ID: 28641096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curative Therapies for Sickle Cell Disease.
    Khemani K; Katoch D; Krishnamurti L
    Ochsner J; 2019; 19(2):131-137. PubMed ID: 31258425
    [No Abstract]   [Full Text] [Related]  

  • 17. Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now.
    Hsieh MM; Fitzhugh CD; Tisdale JF
    Blood; 2011 Aug; 118(5):1197-207. PubMed ID: 21628400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choice of Donor Source and Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Sickle Cell Disease.
    Limerick E; Fitzhugh C
    J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31731790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic stem cell transplantation for adult sickle cell disease in the era of universal donor availibility.
    Aslam HM; Yousuf S; Kassim A; Iqbal SM; Hashmi SK
    Bone Marrow Transplant; 2018 Nov; 53(11):1390-1400. PubMed ID: 29728697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic cellular gene therapy for hemoglobinopathies.
    Gaziev J; Lucarelli G
    Hematol Oncol Clin North Am; 2010 Dec; 24(6):1145-63. PubMed ID: 21075285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.